110 related articles for article (PubMed ID: 1975496)
1. A study on CNS-side effects of mequitazine, an H1-specific antihistamine in healthy Thai volunteers.
Dhorranintra B; Sriprasong T; Limsuvan S; Klyprayong S
Asian Pac J Allergy Immunol; 1990 Jun; 8(1):39-44. PubMed ID: 1975496
[TBL] [Abstract][Full Text] [Related]
2. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.
Theunissen EL; Vermeeren A; van Oers AC; van Maris I; Ramaekers JG
Clin Exp Allergy; 2004 Feb; 34(2):250-8. PubMed ID: 14987305
[TBL] [Abstract][Full Text] [Related]
3. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.
Theunissen EL; Vermeeren A; Ramaekers JG
Br J Clin Pharmacol; 2006 Jan; 61(1):79-86. PubMed ID: 16390354
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
Kamei H; Noda Y; Ishikawa K; Senzaki K; Muraoka I; Hasegawa Y; Hindmarch I; Nabeshima T
Hum Psychopharmacol; 2003 Dec; 18(8):611-8. PubMed ID: 14696020
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Hindmarch I; Shamsi Z; Kimber S
Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730
[TBL] [Abstract][Full Text] [Related]
7. On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.
van der Sluiszen NN; Vermeeren A; Jongen S; Theunissen EL; van Oers AC; Van Leeuwen CJ; Maret A; Desforges C; Delarue A; Ramaekers JG
Psychopharmacology (Berl); 2016 Sep; 233(18):3461-9. PubMed ID: 27488192
[TBL] [Abstract][Full Text] [Related]
8. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled assessment of mequitazine and astemizole in tests of psychomotor ability.
Hindmarch I; Easton JC
Int J Clin Pharmacol Res; 1986; 6(6):457-64. PubMed ID: 3100463
[TBL] [Abstract][Full Text] [Related]
10. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
11. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
[TBL] [Abstract][Full Text] [Related]
12. [The secondary effects of the antihistamine chlorpheniramine on the central nervous system].
Serra-Grabulosa JM; Sánchez-Turet M; Grau C
Rev Neurol; 2002 Jun 16-30; 34(12):1178-82. PubMed ID: 12134286
[TBL] [Abstract][Full Text] [Related]
13. [Comparative trial of 2 antihistaminics: mequitazine and dexchlorpheniramine].
Muler H; Blum F
Ann Otolaryngol Chir Cervicofac; 1978 Jun; 95(6):433-9. PubMed ID: 33589
[No Abstract] [Full Text] [Related]
14. Lack of effect of single and repeated doses of levocetirizine, a new antihistamine drug, on cognitive and psychomotor functions in healthy volunteers.
Gandon JM; Allain H
Br J Clin Pharmacol; 2002 Jul; 54(1):51-8. PubMed ID: 12100225
[TBL] [Abstract][Full Text] [Related]
15. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
16. Some clinical pharmacological studies with terfenadine, a new antihistamine drug.
Kulshrestha VK; Gupta PP; Turner P; Wadsworth J
Br J Clin Pharmacol; 1978 Jul; 6(1):25-9. PubMed ID: 27203
[TBL] [Abstract][Full Text] [Related]
17. Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving.
Tashiro M; Sakurada Y; Mochizuki H; Horikawa E; Maruyama M; Okamura N; Watanuki S; Arai H; Itoh M; Yanai K
Hum Psychopharmacol; 2008 Mar; 23(2):139-50. PubMed ID: 18181241
[TBL] [Abstract][Full Text] [Related]
18. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.
van Ruitenbeek P; Vermeeren A; Riedel W
J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925
[TBL] [Abstract][Full Text] [Related]
19. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects.
Boyle J; Eriksson M; Stanley N; Fujita T; Kumagi Y
Curr Med Res Opin; 2006 Jul; 22(7):1343-51. PubMed ID: 16834833
[TBL] [Abstract][Full Text] [Related]
20. Caffeine counteracts impairments in task-oriented psychomotor performance induced by chlorpheniramine: a double-blind placebo-controlled crossover study.
Kim SW; Bae KY; Shin HY; Kim JM; Shin IS; Kim JK; Kang G; Yoon JS
J Psychopharmacol; 2013 Jan; 27(1):62-70. PubMed ID: 22719016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
